These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3293274)

  • 1. Failure of intravenously infused spleen cells bearing a minor histoincompatibility to delay rejection of skin grafts bearing additional antigens.
    Johnson LL
    Transplantation; 1988 Jul; 46(1):132-7. PubMed ID: 3293274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged minor allograft survival in intravenously primed mice--a test of the veto hypothesis.
    Johnson LL
    Transplantation; 1987 Jul; 44(1):92-7. PubMed ID: 2955554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged minor allograft survival in intravenously primed mice. Effect of recipient's age and of prior immunity to minor H antigens on the priming cells.
    Johnson LL
    Transplantation; 1989 Jun; 47(6):1017-20. PubMed ID: 2660339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation of alloantigens by host cells.
    Sherwood RA; Brent L; Rayfield LS
    Eur J Immunol; 1986 May; 16(5):569-74. PubMed ID: 3516711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor T cell recognition of major and minor histocompatibility alloantigens: selected suppression of MHC-directed responses by minor alloantigen Ts.
    Perry LL; Williams IR; Dirusso S
    J Immunol; 1984 Jul; 133(1):16-23. PubMed ID: 6202781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of a tumour to prime CTL specific for some of the minor H antigens it expresses but not others.
    Johnson LL
    Immunology; 1991 Apr; 72(4):532-6. PubMed ID: 1903766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506.
    Iwata H; Kitagawa S; Sato S; Kosugi A; Hirose H; Hamaoka T; Shearer GM; Fujiwara H
    Transplantation; 1993 Jul; 56(1):173-80. PubMed ID: 7687396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of intravenously infused donor cells that prolong the survival of H-Y-disparate skin grafts.
    Johnson LL
    Transplantation; 1988 Jul; 46(1):167-70. PubMed ID: 3134755
    [No Abstract]   [Full Text] [Related]  

  • 12. The H-Y antigen and its role in natural transplantation.
    Billingham RE; Hings IM
    Hum Genet; 1981; 58(1):9-17. PubMed ID: 7026417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
    Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H
    J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
    Nevala WK; Paul C; Wettstein PJ
    J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
    Ishikawa H; Hino T; Kato H; Suzuki H; Saito K
    J Immunol; 1986 Oct; 137(7):2080-8. PubMed ID: 3489752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anterior chamber-associated immune deviation promotes corneal allograft survival.
    Niederkorn JY; Mellon J
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal tolerance of H-2 alloantigens. II. I region dependence of tolerance expressed to K and D antigens.
    Streilein JW
    Proc R Soc Lond B Biol Sci; 1980 Apr; 207(1169):475-86. PubMed ID: 6104813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.
    Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
    J Exp Med; 1990 Jul; 172(1):105-13. PubMed ID: 2141624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigraft responses to the H-28c antigen by B6 and B6D2F1 mice.
    Johnson LL
    Immunogenetics; 1988; 27(3):159-66. PubMed ID: 2448237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.